Cybin (HELP) Restructuring Costs (2020 - 2022)
Cybin (HELP) posted Restructuring Costs of $106145.8 for Q2 2022, down 60.24% on a QoQ basis from $266935.0 in Q4 2020.
Cybin (HELP) Restructuring Costs (2020 - 2022) Analysis & Trends
Cybin's Restructuring Costs history runs 2 years deep, the most recent figure standing at $106145.8 for Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Cybin | 262.76 Mn | 262.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2022 | 106,145.81 |
| Dec 31, 2020 | 266,935.02 |